Aytas Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 5.84%
- Profit Growth 8.94%
- Ebitda 8.70%
- Net Worth 46.06%
- Total Assets 2.38%
About Aytas Pharmaceutical
Aytas Pharmaceutical Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 June 2017 (Seven years and seven months 11 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vvsatyanarayana Mamidisetti and Satya Mamidisetti serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299TG2017PTC118007
-
Company No.
118007
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jun 2017
-
Date of AGM
19 Dec 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Aytas Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vvsatyanarayana Mamidisetti
|
Director | 29-Jun-2017 | Current |
|
Satya Mamidisetti
|
Director | 18-Feb-2021 | Current |
Financial Performance of Aytas Pharmaceutical.
Aytas Pharmaceutical Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 5.84% increase. The company also saw a slight improvement in profitability, with a 8.94% increase in profit. The company's net worth Soared by an impressive increase of 46.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aytas Pharmaceutical?
In 2020, Aytas Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aytas Pharmaceutical?
Unlock and access historical data on people associated with Aytas Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aytas Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aytas Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
